MONIT GTN 2.6 MG TABLET 1 strip / 30 tablets each (Intas Pharmaceuticals Ltd) Potentially Fatal: Hypotension, paradoxical bradycardia, impaired respiration, syncope and collapse. Buccal tablets: Delayed dissolution, may be swallowed by mistake. Transdermal patches: Contact dermatitis, metal-containing patches should be removed before cardioversion, defibrillation, diathermy. Topical: Contact dermatitis, erythema, local irritation. Sublingual Tabs/Spray: Dry mouth, localised burning sensation. IV admin: IV preparation contains substantial quantities of alcohol and alcohol intoxication can occur. Large doses can cause vomiting, restlessness, hypotension, syncope, rarely cyanosis and methaemoglobinaemia, impaired respiration, bradycardia. Monit GTN side effectsįacial flushing, dizziness, tachycardia, throbbing headache and tolerance. Alcohol may cause severe hypotension and collapse. Potentially Fatal: Orthostatic hypotension may be produced by combined use of calcium channel blockers, antihypertensives, phenothiazines and TCAs. Aspirin and other NSAIDs may reduce the therapeutic response to Monit GTN. Efficacy of buccal and sublingual preparations may be reduced by drugs that can cause dry mouth due to decreased dissolution. May reduce the efficacy of heparin, alteplase and noradrenaline when used together. Monit GTN infusion may prolong pancuronium-induced neuromuscular blockade. Monit GTN interactionsĮnhances bioavailability of dihydroergotamine.
Syringe: Pantoprazole.Īdult: As 0.4% oint: Apply an equivalent of approx 1.5 mg intra-anally 12 hrly for up to 8 wk. Incompatibility: Adsorbed by some plastic IV admin sets, including PVC. Monit GTN is used in the prevention and treatment of the chest pain associated with angina (when the blood supply to the muscles of the heart is restricted).
#MONIT GTN 2.6 USED FOR SKIN#
Prophylaxis of phlebitis and extravasation secondary to venous cannulationĪdult: As patch releasing 2.5-20 mg/24 hr: Apply 5 mg patch distal to the IV site, replace patch at a different skin site either daily or after 3-4 days depending on the patch continue for as long as the IV infusion is maintained. As aerosol spray (400 mcg/spray): 1-2 sprays directed onto or under the tongue, close the mouth after spraying 3 sprays may be used for acute attack.Īdult: As 2% oint: Apply 0.5-2 inches on a convenient area of the skin bid or 3-4 hrly if necessary cover the area after application.Īdult: As patch releasing 2.5-20 mg/24 hr: Apply 1 patch onto a fresh area of skin (chest, upper arms, thigh or shoulder). Seek medical help if pain persists after a total of 3 doses w/in 15 min. Max: 26 mg 4 times daily.Īdult: As 0.4% oint: Apply an equivalent of approx 1.5 mg intra-anally 12 hrly for up to 8 wk.Īdult: As tab: 300-600 mcg, repeat if necessary. Usual range: 10-200 mcg/min doses up to 400 mcg/min may be required in some cases.Īdult: 10-100 mcg/min, w/ the dose initially at the lower rate, then increase gradually according to response.Īdult: Initially, 5-25 mcg/min, adjust according to response.Īdult: As modified-release tab/cap: 2.5-6.5 mg 3-4 times daily, adjust according to response. Induction of hypotension or control of hypertension during surgeryĪdult: Initially, 5-25 mcg/min, adjust according to response. Severe angina: 5 mg may be given.Īdult: Initially, 5-15 mcg/min. Chronic heart failure: 5-10 mg tid.Īdult: 2 mg, placed between the gum and upper lip, increase to 3 mg if necessary. Adult: 5 mg, repeat until symptoms are controlled.
0 kommentar(er)
